Skip to content

Effect of deeper versus standard muscle relaxation on pressure around the eye in patients undergoing laprascopic and robotic abdominal surgery

Effect of deep versus moderate neuromuscular blockade on optic nerve sheath diameter (ONSD) in patients undergoing laparoscopic and robotic abdomino-pelvic surgery in steep Trendelenburg position - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112914
Enrollment
68
Registered
2026-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Deep Neuromuscular blockade: patient will be given deep neuromuscular blockade, following induction, rocuronium infusion will be titrated to maintain post-tetanic count (PTC) 1-2 Contro

Sponsors

Department of Anaesthesiology, AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients classified as American Society of Anesthesiologists (ASA) Physical Status I or II. 2. Patients scheduled for elective robot-assisted or laparoscopic surgery in the steep Trendelenburg position. 3. Pneumoperitoneum time to last longer than one hour or surgical time to last longer than 2 hours

Exclusion criteria

Exclusion criteria: 1. Patients who decline to provide informed consent for the study 2. Patients with known neurological diseases associated with raised or altered intracranial pressure(eg intracranial hypertension, pseudotumour cerebri, epilepsy, hydrocephalus, intracranial tumors, intracranial hemorrhage, traumatic brain injury) 3. Patients with ocular disorders such as glaucoma, optic neuritis that could affect optic nerve sheath diameter measurements. 4. Patients with Severe cardiovascular diseases such as unstable angina, recent MI, decompensated heart failure etc. 5. Patients with Severe pulmonary disease such as COPD grade iii-iv, severe restrictive diseases etc. 6. Patients with Morbid obesity (BMI more than 35 kg/m2) 7. Patients having Allergy or contraindication to study drugs 8. Patients with History of malignant hyperthermia or neuro-muscular disorders 9. Pregnant patients

Design outcomes

Primary

MeasureTime frame
Comparison of optic nerve sheath diameter(ONSD)Timepoint: At 60 min after creation of pneumoperitoneum

Secondary

MeasureTime frame
Intraoperative hemodynamicsTimepoint: baseline, after induction, after pneumoperitoneum, in steep trendelenburg position, after desufflation;Quality of surgical fieldTimepoint: At the end of surgery;Recovery characteristicsTimepoint: Time to reversal Time to extubation;Postoperative neurological symptomsTimepoint: at 2, 6, 12, 24 hours postoperatively;Postoperative painTimepoint: 1,3,6 and 12 hours postoperatively

Countries

India

Contacts

Public ContactDr Priyanka Gupta

All India Institute of Medical Sciences, RIshikesh

drpriyankagupta84@gmail.com9811894899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026